SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: smh who wrote (1429)4/21/2000 11:15:00 AM
From: Vector1  Read Replies (1) | Respond to of 3202
 
Schmidt and Paul Kelly at ING are big time CRA bulls and INCY bashers. Kelly has a sell on INCY.
The INCY CRA debate is heating up. One of the companies has a business plan that works and is already producing $200m a year in revenue. The other while it has powerful technology is still evolving,
V1



To: smh who wrote (1429)4/23/2000 12:17:00 AM
From: Dave K  Read Replies (1) | Respond to of 3202
 
>> This is the sharpest contradiction of one analyst by another, sitting on the same panel, I have ever seen. <<

Yeah, but Rachel a lot smarter....and cute_r ! <g>


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News